Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

por Shustik, C., Bence-Bruckler, I., Delage, R., Owen, C. J., Toze, C. L., Coutre, S.
Publicado 2017

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

por Rule, S, Jurczak, W, Jerkeman, M, Rusconi, C, Trneny, M, Offner, F, Caballero, D, Joao, C, Witzens-Harig, M, Hess, G, Bence-Bruckler, I, Cho, S-G, Thieblemont, C, Zhou, W, Henninger, T, Goldberg, J, Vermeulen, J, Dreyling, M
Publicado 2018